HOLLY ROWELL: Open Payments
NPI 1588173579 · DILLON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$880 in 44 payments from 14 companies in 2025. Trend: 2023 $602 · 2024 $451 · 2025 $880
Food & beverage: $880
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $327 |
| Exact Sciences Corporation | 5 | $101 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $73 |
| GlaxoSmithKline, LLC. | 4 | $61 |
| Sumitomo Pharma America, Inc. | 3 | $60 |
| Abbott Laboratories | 3 | $59 |
| PFIZER INC. | 3 | $49 |
| Lilly USA, LLC | 2 | $35 |
| Corcept Therapeutics | 2 | $31 |
| Daiichi Sankyo Inc. | 1 | $22 |
Products named: Ozempic, Wegovy, Cologuard Collection Kit, XIFAXAN, GEMTESA, FREESTYLE LIBRE 3, TRELEGY ELLIPTA, PREVNAR 20.
Industry payments across SC — which companies pay providers there.
